Scientific Company Directory

Scientific Company Directory

The latest research, products, and discoveries from the science industry’s leading companies and company divisions.

NEW

Scientific Products

From innovative tools to essential equipment and supplies, find everything you need to advance your research on our new Scientific Products page.

Search Scientific Products
  • ALL
    • |
  • A
    • |
  • B
    • |
  • C
    • |
  • D
    • |
  • E
    • |
  • F
    • |
  • G
    • |
  • H
    • |
  • I
    • |
  • J
    • |
  • K
    • |
  • L
    • |
  • M
    • |
  • N
    • |
  • O
    • |
  • P
    • |
  • Q
    • |
  • R
    • |
  • S
    • |
  • T
    • |
  • U
    • |
  • V
    • |
  • W
    • |
  • X
    • |
  • Y
    • |
  • Z
    • Beckman Coulter Life Sciences is a leading developer of scientific research technologies that primarily serve the academia and pharmaceutical markets. The company also develops and manufacture solutions for clinical research and for applied markets such as agricultural, food and beverage, gas and oil, aerospace, and several others.

    BMG LABTECH is a leading global manufacturer of innovative, high-quality, and reliable microplate reader instrumentation.

    BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to better diagnose disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com.
    BrainXell focuses on neural cells for therapeutic development. Founded in 2015 by Prof. Su-Chun Zhang with help from the Discovery to Product (D2P) program of University of Wisconsin Madison, it is based on the proprietary technology of directed differentiation of human stem cells (including induced pluripotent stem cells) to highly enriched subclasses of neurons. BrainXell is developing drug discovery / toxicology testing platforms using patient-derived or genetically modified stem cells for as well as provide services to pharmaceutical and biotechnology industry. BrainXell also aims to develop stem cell therapy for neurological injuries and diseases through collaboration with pharmaceutical and healthcare industry. BrainXell's goal is to make our brain healthy and well.

    Biosearch Technologies is the comprehensive genomics portfolio from LGC, providing products and services for genomic analysis that support mission critical applications for global customers in agrigenomics and human healthcare.

     

    The portfolio offers integrated tools and technologies to accelerate sample preparation, amplification, cloning and expression, next generation sequencing (NGS), custom oligonucleotide synthesis, nucleic acid chemistry reagents, and oligo therapeutics.

     

    Whether through sbeadex™ DNA purification, oligos and reagents (KASP™, BHQplus™ Probes, BHQ™ Probe Master Mix), or proprietary sample prep and PCR instrumentation (oKtopure™, SNPline™, Nexar™ and IntelliQube™), we enable our customers from discovery to production-scale testing.

     

    Biosearch Technologies is a leader in the agricultural genomics market and is increasingly adopted by researchers, with over 2,000 scientific papers citing KASP assays. Key applications include validation and screening of newly discovered SNPs in Marker-Assisted Selection and Marker-Assisted Breeding programmes for both plants and livestock.

     

    Globally, our cGMP manufacturing and ISO 13485-compliant facilities support supply chain continuity, complementing our customers’ product development pipelines through our robust research grade and cGMP oligonucleotide manufacturing that achieves consistent scale up. For molecular diagnostics, Biosearch Technologies has proven expertise in NGS, isothermal, qPCR-based applications where our tools and technologies such as BHQ probes and proprietary PCR platforms are frequently used in LDTs, ASRs and in vitro diagnostics. Through our recently acquired Lucigen portfolio, we also offer custom and bulk enzymes and buffers as critical components for molecular diagnostics.

     

    Sales offices are located in China, Germany, Singapore, UK, and US. Sales representatives are available throughout Europe, Latin America, and Asia Pacific, with distributors in other key territories. Visit www.biosearchtech.com.

    Bio-Techne empowers researchers in Life Sciences and Clinical Diagnostics by providing high-quality reagents, instruments, custom manufacturing, and testing services. Our family of brands creates a unique portfolio of products and services. Science is our passion; it drives us to collaborate, develop, and manufacture award-winning tools that help researchers achieve reproducible and consistent results. Whether you are at the cutting edge of academic research, translating basic discoveries to therapeutic leads, or at a facility that requires the highest level of diagnostic testing, our innovative products and services provide the solutions you need to achieve success.
    Burning Rock Dx (NASDAQ: BNR) is a global diagnostics company focusing on applying next-generation sequencing (NGS) technology in precision oncology. Guided by the mission of "Guard Life via Science," Burning Rock offers solutions covering the entire precision oncology development cycle through an internally developed NGS-based assay portfolio for both tissue and blood samples, along with a robust in-house database to help facilitate clinical trial studies and research. Burning Rock provides dedicated services to pharmaceutical partners, encompassing genomic data solutions, clinical trial solutions, precision patient recruitment, and companion diagnostics (CDx) development and commercialization. Burning Rock's diverse portfolio operates out of their two CLIA/CAP laboratories in China and the United States, allowing for global clinical trial support. Burning Rock has achieved two NMPA-approved IVD kits, four assays with CE marking, and a breakthrough device designation (BDD) received from both US FDA and China NMPA for multi-cancer detection blood test. Leveraging their robust NGS technology and extensive experience in pharmaceutical and project partnerships, Burning Rock stands as a global collaborator in driving advancements in precision oncology.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, helping people live longer, healthier lives.
    Bruker offers advanced preclinical imaging and fluorescence microscopy solutions for a broad spectrum of application fields: oncology, neurology, cardiology, inflammation, infectious diseases, cancer research, functional and anatomical neuroimaging, orthopedics, cardiac imaging, stroke models, and in vivo imaging of the nervous system, optogenetics, in vitro imaging of brain slices in conjunction with electrophysiology, cellular imaging and imaging cell structure at the molecular level. Our range of techniques includes two-photon, confocal, and super-resolution fluorescence microscopes, magnetic resonance imaging (MRI), PET/MRI imaging, Optical Imaging, PET/SPECT/CT imaging, micro-CT and magnetic particle imaging (MPI) as well as MALDI Imaging.

    BioLegend develops world-class, cutting-edge antibodies, recombinant proteins, bioassays, and other reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, California. Our mission is to accelerate research and discovery by providing the highest quality products at an outstanding value, along with superior customer service and technical support. BioLegend was incorporated in June, 2002. The founder and CEO of BioLegend, Gene Lay, D.V.M., who was also the co-founder of PharMingen.

    For 60 years The Baker Company has been at the forefront of engineering, testing and production of reliable laboratory contamination control equipment. Recognized as the industry pioneer, The Baker Company maintains an unparalleled passion for helping our customers advance science, discovery, and clinical care. The people of Baker have built that reputation by taking no chances with customers' safety and making no compromises when it comes to protecting the success of your research. Baker's laboratory products are built to order with precision craftsmanship and designed expressly for your unique application need. Our rigorous testing protocols go above and beyond what the average user would ever encounter and our quality control measures exceed industry standards. Our commitment to sustainable business practices and the development of a new generation of energy efficient products ensures that you - and your budget - will be pleased.

    At Bionano, we are committed to unlocking the understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. Our team is not afraid to venture into uncharted territory to look for answers. We welcome the curious and provide a place where those who are not satisfied with the status quo can feel at home.

    For more than 50 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific research instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics. For more information, please visit www.bruker.com.

    Biocompare (www.biocompare.com) is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information. Produced by scientists, Biocompare's mission is to provide free, time saving services to life science researchers, allowing scientists to find and learn about the technologies that drive discovery. Biocompare does this by providing specialized search tools, articles, product reviews, webinars, videos and technology spotlights all designed to ensure that Biocompare remains a trusted and comprehensive source of product information. Biocompare continually strives to serve the life science community by providing new and improved online services that facilitate product discovery and technology education.
    Binding Site is committed to improving patient lives worldwide through education, collaboration, and innovation. We do this by providing automated special protein instruments and a wide range of high quality assays, with over 20 new assays FDA cleared in 2013 and 2014. Binding Sites SPAPLUS special protein analyzer is the newest, most efficient, cost-effective, and reliable instrument solution available for special protein testing. With a comprehensive menu of over 30 assays, the SPAPLUS is the perfect complement for todays lab. The Freelite assays, developed and provided exclusively by Binding Site, are considered standard-of-care for the diagnosis of Myeloma and other monoclonal gammopathies. Binding Sites Hevylite assays are now available in the U.S. Hevylite is a novel test for measurement of Myeloma serum proteins. Hevylite test results are used together with Freelite in the management of Myeloma patients. Binding Site is also the market leader for IgG and IgA immunoglobulin subclass reagents. In addition to our in vitro diagnostic portfolio, we provide a comprehensive product offering of antibodies, antigens, clinical specimens, collaborative immunoassay reagents, disease state sera, substrates, and contact manufacturing services for IVD manufacturers and suppliers. The Freelite assays, developed and provided exclusively by Binding Site, are considered standard-of-care for the diagnosis of Myeloma and other monoclonal gammopathies and suppliers.
    A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory's role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time - and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what's now to what's next. We do this by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Beckman Coulter is part of the Danaher Corporation family of global science and technology companies. Headquartered in Brea, Calif., it has more than 11,000 global team members.
    BioTek Instruments, Inc., a part of Agilent Technologies, is a global leader in the development, manufacture and sale of life science instrumentation, including imaging & microscopy, multi-mode detection, liquid handling and automation systems. Our philosophy transcends conventional thinking and challenges the status quo. We develop fresh, original solutions by unifying concepts that often appear to be opposed. It means to shape and reshape. To engineer, build, deliver and support products that best serve the marketplace by providing what you need, when you need it.
    Boster is an antibody manufacturer founded in 1993 by famed histologist, Steven Xia. Over the past two decades, Boster's products have been cited in over 12,000 publications. We specialize in developing ELISA kits and antibodies with high affinity and at affordable prices. One thing that sets us apart from our competitors is that we thoroughly test all antibodies using un-"spiked" (not transfected) tissues and cell lines to ensure they have enough affinity to react with the endogenous levels of the targets before providing them to our customers.
    Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books (under the Bentham Books brand) have an ever-increasing readership of millions of researchers worldwide.
    BioMed Central is an STM (Science, Technology and Medicine) publisher of 265 peer-reviewed open access journals. The portfolio of journals spans all areas of biology, biomedicine and medicine and includes broad interest titles, such as BMC Biology and BMC Medicine alongside specialist journals, such as Retrovirology and BMC Genomics. All original research articles published by BioMed Central are made freely accessible online immediately upon publication. BioMed Central levies an article-processing charge to cover the cost of the publication process. Authors publishing with BioMed Central retain the copyright to their work, licensing it under the Creative Commons Attribution License which allows articles to be re-used and re-distributed without restriction, as long as the original work is correctly cited. BioMed Central is owned by Springer Science+Business Media, and also hosts the SpringerOpen platform.